Retinal Disorder Treatment Market - Global Industry Analysis

Retinal Disorder Treatment Market By Type (Macular Degeneration, Diabetic Retinopathy, and Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, and Ointments) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 27-Jul-2022 Category: Healthcare Report Format : PDF Pages: 251 Report Code: ZMR-5451 Status : Published

The global retinal disorder treatment market size was worth USD 10,271.4 million in 2021 and is estimated to grow to USD 15,675.74 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.30% over the forecast period.

Description

Industry Perspective:

The global retinal disorder treatment market size was worth USD 10,271.40 million in 2021 and is estimated to grow to USD 15,675.74 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.30% over the forecast period. The report analyzes the retinal disorder treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the retinal disorder treatment market.

Retinal Disorder Treatment Market: Overview

The retina is a very sensitive and intricate element of the human eye system that serves as a light receiver and processor, converting light into neural impulses and transporting them to the brain for visual processing. Retinal function and structure are impacted by retinal illnesses such as diabetic retinopathy, age-related macular edema, retinoblastoma, degeneration, infectious retinitis, retinoschisis, retinal degeneration, and others. Over the last few decades, retinal problems have garnered a lot of attention from researchers and other professionals. The increased prevalence of retinal illnesses worldwide, as well as the demand for effective and economical treatment alternatives, has fueled the industry. In addition, the growing geriatric population is also expected to significantly impact the entire industry. Over the projected period, strong pipeline products are expected to be one of the primary drivers driving the market for retinal condition therapy. Other factors expected to drive the retinal disorder treatment market include technological developments and increased strategic alliances. Advances in technology and hopeful findings from research & development operations have contributed to the overall development of the global retinal disorder treatment market in recent years, a trend that is anticipated to last for the duration of the forecast.

Global Retinal Disorder Treatment Market

COVID-19 Impact:

The emergence of the COVID-19 pandemic is predicted to have a moderate impact on the worldwide retinal disorder treatment market's overall growth in 2020. While the primary focus is expected to remain on the creation of new vaccines, research and development operations in other medical fields are expected to continue as planned. It is also expected that research will be conducted to assess the occurrence of retinal changes in patients infected with the novel COVID-19 virus. In addition, doctors and specialists are anticipated to rely on telemedicine services due to the ongoing risk of getting the virus. Even though statistics indicate that individuals are willing to postpone treatment for retinal problems because of the ongoing epidemic.

Key Insights

  • As per the analysis shared by our research analyst, the global retinal disorder treatment market value at a CAGR of 7.30% over the forecast period.
  • In terms of revenue, the global retinal disorder treatment market size was valued at around USD 10,271.40 million in 2021 and is projected to reach USD 15,675.74 million, by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
  • The increased prevalence of retinal illnesses worldwide, as well as the demand for effective and economical treatment alternatives, has fueled the industry.
  • By type, the macular degeneration segment dominated the market in 2021.
  • By dosage form, the eye solution segment dominated the market in 2021.
  • North America dominated the global retinal disorder treatment market in 2021.

Retinal Disorder Treatment Market: Growth Drivers

Increasing new technologies is likely to pave the way for global market growth

In the next years, technological developments are expected to significantly influence the overall growth of the worldwide retinal disorder treatment market. In the coming decade, groundbreaking innovations and improvements in bionics, genetics, and stem-cell therapy are likely to revolutionize the future of retinal disorder treatment. Retinal degeneration has emerged as one of the leading causes of blindness or visual impairment in industrialized nations when preventable causes of blindness are recognized early, thanks to periodic checks and a robust healthcare ecosystem. Advances on multiple new fronts are likely to pave the door for new retinal disease treatments for all major types of retinal abnormalities.

Retinal Disorder Treatment Market: Restraints

High costs related to treatment may hamper the global market growth

In numerous developing countries, the market for the treatment of retinal illnesses has grown slowly due to a variety of problems, including the high expenses associated with those treatments, steep expenditures, and unreliability of the equipment used.

Retinal Disorder Treatment Market: Opportunities

Wearable technology trends and investment in pain management bring up several growth opportunities

The market for treating retinal disorders is anticipated to develop as a result of the rising prevalence of inherited retinal illnesses. The global retinal disorder treatment market is anticipated to develop due to rising awareness and treatment utilization rates. The market is predicted to rise as people become more aware of the disease's diagnosis choices and available treatment options. The World Health Organization estimates that over 2.2 billion individuals worldwide have a vision issue. The enormous patient base experiencing eye problems is what fuels market expansion.

Retinal Disorder Treatment Market: Segmentation

The global retinal disorder treatment market is segregated on the basis of type, dosage form, distribution channel, and region.

By type, the market is divided into macular degeneration, diabetic retinopathy, and others. Among these, the macular degeneration segment dominated the market in 2021and is expected to be the fastest-growing sector over the forecast period. One of the primary drivers driving category expansion is introducing new products to treat macular degeneration. Additionally, rising awareness of this type of retinal condition is likely to drive market growth throughout the projection period.

Based on dosage form, the market is divided into gels, eye solutions, capsules & tablets, eye drops, and ointments. Among these, the eye solutions segment dominated the market in 2021.

The distribution channel divides the market into hospital pharmacies, online pharmacies, and retail pharmacies. Over the forecast period, the hospital pharmacy segment is expected to develop fastest. This is because many people are treated and cared for at hospitals. Aside from that, better healthcare plans and reimbursement rules propel this industry. In addition, rising investments in the health sector in underdeveloped and developing economies are also fueling the industry.

Recent Developments

  • In March 2021, multi-year research collaboration and licensing agreement between SemaThera Inc. and Roche was announced to promote SemaThera's innovative biologics portfolio for the treatment of ischemic retinal illnesses such diabetic retinopathy.
  • In February 2019, SightMatters.com, a new educational online resource for persons with age-related macular degeneration, was launched by Bausch & Lomb Incorporated.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Retinal Disorder Treatment Market: Regional Landscape

Rising prevalence of retinal disorders is likely to help North America dominate the global market

North America dominated the global retinal disorder treatment market in 2021. Eye illnesses are seen as a persistent issue in the United States and other countries throughout the world. Because of increased cases of macular degeneration, uveitis, diabetic retinopathy, and other diseases, North America accounted for the largest market. The rising prevalence of retinal diseases is likely to fuel the expansion of the retinal disorder treatment market in this area. Rising awareness and treatment-seeking rates are likely to drive the growth of the market. Furthermore, strong pipeline medicines to treat retinal illnesses are projected to provide considerable development possibilities in the market during the forecast period.

Over the forecast period, Asia Pacific regional market is expected to grow significantly in the retinal disorder treatment market. High unmet clinical requirements, the availability of efficient treatment options, increased disposable income, and greater knowledge of early diagnosis in developing nations can all be considered causes of this. In addition, the market has also been pushed by the rising prevalence of retinal illnesses worldwide and the demand for efficient & reasonably priced treatment options. Additionally, promising pipeline therapies to treat retinal disorders is anticipated to present the market with sizable potential prospects throughout the projected period.

Retinal Disorder Treatment Market: Competitive Landscape

Some of the main competitors dominating the global retinal disorder treatment market include - Santen Pharmaceutical Co., Ltd., REGENERON, Graybug Vision, Inc., Genentech, Inc., Shire (Takeda Pharmaceutical Company Limited), Bayer AG, Pfizer, Inc. and Acucela Inc.

The Global Retinal Disorder Treatment market is segmented as follows:

By Type

  • Macular Degeneration
  • Diabetic Retinopathy
  • Others

By Dosage Form

  • Gels
  • Eye Solutions
  • Capsules & Tablets
  • Eye Drops
  • Ointments

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Retinal Disorder Treatment Market, (2022 - 2028) (USD Million)
    • 2.2 Global Retinal Disorder Treatment Market : snapshot
  • Chapter 3. Global Retinal Disorder Treatment Market - Industry Analysis
    • 3.1 Retinal Disorder Treatment Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing new technologies is likely to pave the way for global market growth
    • 3.3 Market Restraints
      • 3.3.1. High costs related to treatment may hamper the global market growth
    • 3.4 Market Opportunities
      • 3.4.1. Wearable technology trends and investment in pain management to bring up several growth opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type
      • 3.7.2 Market attractiveness analysis By Dosage Form
      • 3.7.3 Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Retinal Disorder Treatment Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Retinal Disorder Treatment Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Retinal Disorder Treatment Market - Type Analysis
    • 5.1 Global Retinal Disorder Treatment Market overview: By Type
      • 5.1.1 Global Retinal Disorder Treatment Market share, By Type, 2021 and 2028
    • 5.2 Macular Degeneration
      • 5.2.1 Global Retinal Disorder Treatment Market by Macular Degeneration, 2022 - 2028 (USD Million)
    • 5.3 Diabetic Retinopathy
      • 5.3.1 Global Retinal Disorder Treatment Market by Diabetic Retinopathy, 2022 - 2028 (USD Million)
    • 5.4 Others
      • 5.4.1 Global Retinal Disorder Treatment Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Retinal Disorder Treatment Market - Dosage Form Analysis
    • 6.1 Global Retinal Disorder Treatment Market overview: By Dosage Form
      • 6.1.1 Global Retinal Disorder Treatment Market share, By Dosage Form, 2021 and 2028
    • 6.2 Gels
      • 6.2.1 Global Retinal Disorder Treatment Market by Gels, 2022 - 2028 (USD Million)
    • 6.3 Eye Solutions
      • 6.3.1 Global Retinal Disorder Treatment Market by Eye Solutions, 2022 - 2028 (USD Million)
    • 6.4 Capsules & Tablets
      • 6.4.1 Global Retinal Disorder Treatment Market by Capsules & Tablets, 2022 - 2028 (USD Million)
    • 6.5 Eye Drops
      • 6.5.1 Global Retinal Disorder Treatment Market by Eye Drops, 2022 - 2028 (USD Million)
    • 6.6 Ointments
      • 6.6.1 Global Retinal Disorder Treatment Market by Ointments, 2022 - 2028 (USD Million)
  • Chapter 7. Global Retinal Disorder Treatment Market - Distribution Channel Analysis
    • 7.1 Global Retinal Disorder Treatment Market overview: By Distribution Channel
      • 7.1.1 Global Retinal Disorder Treatment Market share, By Distribution Channel, 2021 and 2028
    • 7.2 Hospital Pharmacy
      • 7.2.1 Global Retinal Disorder Treatment Market by Hospital Pharmacy, 2022 - 2028 (USD Million)
    • 7.3 Online Pharmacy
      • 7.3.1 Global Retinal Disorder Treatment Market by Online Pharmacy, 2022 - 2028 (USD Million)
    • 7.4 Retail Pharmacy
      • 7.4.1 Global Retinal Disorder Treatment Market by Retail Pharmacy, 2022 - 2028 (USD Million)
  • Chapter 8. Retinal Disorder Treatment Market - Regional Analysis
    • 8.1 Global Retinal Disorder Treatment Market Regional Overview
    • 8.2 Global Retinal Disorder Treatment Market Share, by Region, 2021 & 2028 (USD Million)
    • 8.3. North America
      • 8.3.1 North America Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
        • 8.3.1.1 North America Retinal Disorder Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 North America Retinal Disorder Treatment Market, by Type, 2022 - 2028
      • 8.4.1 North America Retinal Disorder Treatment Market, by Type, 2022 - 2028 (USD Million)
    • 8.5 North America Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028
      • 8.5.1 North America Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028 (USD Million)
    • 8.6 North America Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028
      • 8.6.1 North America Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 8.4. Europe
      • 8.4.2 Europe Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
        • 8.4.2.1 Europe Retinal Disorder Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Europe Retinal Disorder Treatment Market, by Type, 2022 - 2028
      • 8.4.1 Europe Retinal Disorder Treatment Market, by Type, 2022 - 2028 (USD Million)
    • 8.5 Europe Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028
      • 8.5.1 Europe Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028 (USD Million)
    • 8.6 Europe Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028
      • 8.6.1 Europe Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
        • 8.5.3.1 Asia Pacific Retinal Disorder Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Asia Pacific Retinal Disorder Treatment Market, by Type, 2022 - 2028
      • 8.4.1 Asia Pacific Retinal Disorder Treatment Market, by Type, 2022 - 2028 (USD Million)
    • 8.5 Asia Pacific Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028
      • 8.5.1 Asia Pacific Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028 (USD Million)
    • 8.6 Asia Pacific Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028
      • 8.6.1 Asia Pacific Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 8.6. Latin America
      • 8.6.4 Latin America Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
        • 8.6.4.1 Latin America Retinal Disorder Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 Latin America Retinal Disorder Treatment Market, by Type, 2022 - 2028
      • 8.4.1 Latin America Retinal Disorder Treatment Market, by Type, 2022 - 2028 (USD Million)
    • 8.5 Latin America Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028
      • 8.5.1 Latin America Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028 (USD Million)
    • 8.6 Latin America Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028
      • 8.6.1 Latin America Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
        • 8.7.5.1 The Middle-East and Africa Retinal Disorder Treatment Market, by Country, 2022 - 2028 (USD Million)
    • 8.4 The Middle-East and Africa Retinal Disorder Treatment Market, by Type, 2022 - 2028
      • 8.4.1 The Middle-East and Africa Retinal Disorder Treatment Market, by Type, 2022 - 2028 (USD Million)
    • 8.5 The Middle-East and Africa Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028
      • 8.5.1 The Middle-East and Africa Retinal Disorder Treatment Market, by Dosage Form, 2022 - 2028 (USD Million)
    • 8.6 The Middle-East and Africa Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028
      • 8.6.1 The Middle-East and Africa Retinal Disorder Treatment Market, by Distribution Channel, 2022 - 2028 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1 Santen Pharmaceutical Co. Ltd.
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 REGENERON
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Graybug Vision Inc.
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Genentech Inc.
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Shire (Takeda Pharmaceutical Company Limited)
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 Bayer AG
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Pfizer Inc.
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Acucela Inc.
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Retinal Disorder Treatment Market attractiveness, By Type
  • 6. Global Retinal Disorder Treatment Market attractiveness, By Dosage Form
  • 7. Global Retinal Disorder Treatment Market attractiveness, By Distribution Channel
  • 8. Global Retinal Disorder Treatment Market share by Type, 2022 and 2028 (USD Million)
  • 9. Global Retinal Disorder Treatment Market by Macular Degeneration, 2022 - 2028 (USD Million)
  • 10. Global Retinal Disorder Treatment Market by Diabetic Retinopathy, 2022 - 2028 (USD Million)
  • 11. Global Retinal Disorder Treatment Market by Others, 2022 - 2028 (USD Million)
  • 12. Global Retinal Disorder Treatment Market share by Dosage Form, 2022 and 2028 (USD Million)
  • 13. Global Retinal Disorder Treatment Market by Gels, 2022 - 2028 (USD Million)
  • 14. Global Retinal Disorder Treatment Market by Eye Solutions, 2022 - 2028 (USD Million)
  • 15. Global Retinal Disorder Treatment Market by Capsules & Tablets, 2022 - 2028 (USD Million)
  • 16. Global Retinal Disorder Treatment Market by Eye Drops, 2022 - 2028 (USD Million)
  • 17. Global Retinal Disorder Treatment Market by Ointments, 2022 - 2028 (USD Million)
  • 18. Global Retinal Disorder Treatment Market share by Distribution Channel, 2022 and 2028 (USD Million)
  • 19. Global Retinal Disorder Treatment Market by Hospital Pharmacy, 2022 - 2028 (USD Million)
  • 20. Global Retinal Disorder Treatment Market by Online Pharmacy, 2022 - 2028 (USD Million)
  • 21. Global Retinal Disorder Treatment Market by Retail Pharmacy, 2022 - 2028 (USD Million)
  • 22. Global Retinal Disorder Treatment Market share, by Region, 2022 and 2028
  • 23. North America Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
  • 24. Europe Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
  • 25. Asia Pacific Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
  • 26. Latin America Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)
  • 27. The Middle-East and Africa Retinal Disorder Treatment Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Retinal Disorder Treatment Market: Snapshot
  • 2. Drivers of the Retinal Disorder Treatment Market: impact analysis
  • 3. North America Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 4. North America Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 5. North America Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 6. U.S. Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 7. U.S. Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 8. U.S. Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 9. Canada Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 10. Canada Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 11. Canada Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 12. Europe Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 13. Europe Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 14. Europe Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 15. Germany Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 16. Germany Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 17. Germany Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 18. France Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 19. France Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 20. France Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 21. U.K. Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 22. U.K. Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 23. U.K. Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 24. Italy Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 25. Italy Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 26. Italy Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 27. Spain Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 28. Spain Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 29. Spain Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 30. Rest of Europe Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 31. Rest of Europe Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 32. Rest of Europe Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 33. Asia Pacific Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 34. Asia Pacific Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 35. Asia Pacific Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 36. China Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 37. China Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 38. China Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 39. Japan Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 40. Japan Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 41. Japan Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 42. India Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 43. India Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 44. India Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 45. South Korea Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 46. South Korea Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 47. South Korea Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 48. South-East Asia Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 49. South-East Asia Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 50. South-East Asia Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 51. Rest of Asia Pacific Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 52. Rest of Asia Pacific Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 53. Rest of Asia Pacific Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 54. Latin America Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 55. Latin America Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 56. Latin America Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 57. Brazil Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 58. Brazil Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 59. Brazil Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 60. Mexico Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 61. Mexico Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 62. Mexico Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 63. Rest of Latin America Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 64. Rest of Latin America Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 65. Rest of Latin America Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 66. The Middle-East and Africa Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 67. The Middle-East and Africa Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 68. The Middle-East and Africa Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 69. GCC Countries Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 70. GCC Countries Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 71. GCC Countries Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 72. South Africa Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 73. South Africa Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 74. South Africa Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 75. Rest of Middle-East Africa Retinal Disorder Treatment Market revenue, By Type, 2022 - 2028 (USD Million)
  • 76. Rest of Middle-East Africa Retinal Disorder Treatment Market revenue, By Dosage Form, 2022 - 2028 (USD Million)
  • 77. Rest of Middle-East Africa Retinal Disorder Treatment Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The increased prevalence of retinal illnesses worldwide, as well as the demand for effective and economical treatment alternatives, has fueled the industry. In addition, the growing geriatric population is also expected to significantly impact the entire industry. Over the projected period, strong pipeline products are expected to be one of the primary drivers driving the market for retinal condition therapy.

According to the report, the global Retinal Disorder Treatment market was worth 10,271.40 (USD million) in 2021 and is predicted to grow to 15,675.74 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 7.30%.

North America dominated the Retinal Disorder Treatment Market in 2021. Eye illnesses are seen as a persistent issue in the United States and other countries throughout the world. Because of increased macular degeneration, uveitis, diabetic retinopathy, and other diseases, America accounted for the largest market. The rising prevalence of retinal diseases is likely to fuel the expansion of the retinal disorder treatment market in this area.

Some of the main competitors dominating the Global Retinal Disorder Treatment market include - Santen Pharmaceutical Co., Ltd., REGENERON, Graybug Vision, Inc., Genentech, Inc., Shire (Takeda Pharmaceutical Company Limited), Bayer AG, Pfizer, Inc. and Acucela Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed